Home Shaihe Medical Raises Over RMB 200 Million in Series B; Aiolos Bio Secures $245 Million in Series A and Files IPO Prospectus

Shaihe Medical Raises Over RMB 200 Million in Series B; Aiolos Bio Secures $245 Million in Series A and Files IPO Prospectus

Oct 31, 2023 12:56 CST Updated 12:56
SONOSEMI

Active Vascular Implantable and Interventional Medical Device R&D and Manufacturer

Aiolos Bio

Developer of Respiratory and Inflammatory Disease Treatments

(This article isTitanium Media Pro (Professional Edition)(For User's Exclusive Use)

"TMT Pro Weekly Report" aggregates domestic and international financing events and hotspots of the week through TMTBase, the global primary market database of TMT, aiming to enable investors and entrepreneur users to clearly understand trends, grasp investment logic, and seize the latest industrial opportunities with a time and data-intensive approach.

Industry Report Catalog

The full report contains 9,059 words and 6 illustrations.

1. Industry Key Introduction

2. Primary Market Dynamics

2.1, Financing Dynamics in China Over the Past Two Weeks (Figure: Financing Project Details/Fields/Stages)

2.2、Project Recommendation by Titanium Media Pro in China

2.3, Overseas Two-week Financing Dynamics (Figure: Financing Project Details/Field/Stage)

2.4、International Titanium Media Pro·Project Recommendation

3. Industry Observation

4. Industry Policy

Last Issue Review:[Healthcare Weekly] Week 42: "Nuclear Ark Pharmaceuticals," focused on innovative targeted radioligand drugs, completes multi-million-dollar seed financing; "Actym Therapeutics," a provider of novel drugs for solid tumors, secures $59.5 million in Series A funding.

For project exposure, please send project materials to: tmtpro@tmtpost.com

Key Reading Points

A total of 43 global investment and financing projects in the medical and health field were recorded, including 23 domestic financings and 20 overseas financings. In terms of financing areas, there were 10 investment and financing events in China's medical device and hardware sector, ranking first, while the pharmaceuticals sector had 8 events, ranking second. Overseas, the medical informatization field saw 8 investment and financing events, ranking first, with biotechnology and pharmaceuticals each having 4 events, tying for second place.

In terms of domestic investment and financing, in the field of medical devices and hardware, SONOSEMI, a provider of active interventional diagnosis and treatment solutions for泛血管, has completed a B-round financing of over 200 million RMB. Pulse Medical Manufacturing, a producer of medical device materials and components, has completed a new round of financing worth several hundred million RMB.

In terms of overseas investment and financing, in the pharmaceutical field, Aiolos Bio, a clinical-stage biopharmaceutical startup, completed an oversubscribed $245 million Series A financing round; in the biotechnology field, Rampart Bioscience, a biotech startup, secured $85 million in Series A funding.

From October 23, 2023, to October 29, 2023, the TMTBASE global primary market database of Titanium Media recorded a total of 43 financing events in the healthcare sector, both domestically and internationally. Among them, there were 23 domestic financings and 20 international financings.

Financing Dynamics in China for the Past Week

✔. In the past week, the TMTBASE global primary market database of Titanium Media recorded a total of 13 financing and investment events in the medical and health field in China, marking a 21.05% increase from the previous week.

✔. In terms of the number of financings, there were 10 investment and financing activities in the medical device and hardware field, 8 in the pharmaceuticals field, 3 in the medical informatization field, and 1 each in the biotechnology and health consumption fields.

✔. In terms of financing rounds, there were 3 at the Angel round, 1 each at the Angel+ round, Pre-A round, and Pre-A+ round, 3 at the A+ round, 1 at the Pre-B round, 2 at the B round, 5 in equity investments, 4 in strategic investments, and 2 in mergers and acquisitions.

✔. There were 4 disclosed financing projects with amounts over 100 million RMB in the past week, including 3 in the medical device and hardware field and 1 in the pharmaceutical field.

Recommended Projects by Titanium Media Pro in China

Medical Devices and Hardware

"SONOSEMI" Completes Over 200 Million Yuan in Series B Financing

Recently, "SONOSEMI" has completed a B-round financing of over 200 million RMB. This round of financing was jointly led by Yuexiu Industrial Fund and Jianxin Equity, with Cornerstone Capital participating as a follower. Original shareholders Tencent Investment, Eight Roads Ventures, and Yahui Investment continued to increase their investment. The funds raised in this round will be used for the research, development, production, and commercialization of core products.

SONOSEMI, founded in April 2020 and headquartered in Shenzhen, has independently developed innovative active interventional products for pan-vascular applications during its three years of development, including a coronary intravascular shockwave treatment system, a peripheral arterial intravascular shockwave treatment system, an intracardiac ultrasound imaging system, and intravascular ultrasound. It is expected that by the end of 2024, the company will form a product matrix consisting of 4-6 products to provide customers with comprehensive integrated solutions.

"MAITONG INTELLIGENCE" Completes New Round of Financing Worth Hundreds of Millions

Recently, Zhejiang Maitong Intelligent Manufacturing completed a new round of financing worth several hundred million yuan. This round was led by Fuyuan Investment, with strategic investors including C&D Emerging Investment, Ruili Investment, E Fund, and Jinhe Capital participating.

In the high-end medical device industry, Maitong Intelligence provides integrated services in polymer materials, metal materials, smart materials, film materials, CDMO, and testing. It is committed to offering comprehensive raw material, CDMO, and testing solutions to global high-end medical device companies, pursuing long-term and stable partnerships with clients.

....

For overseas weekly financing events, recommended projects, and policy updates this week, see the full report.

----------------

*This is the simplified version of Pro Weekly Report*

To view the full report, please clickhttps://www.tmtpost.com/proBecome a Titanium Media Pro user to view the full "Titanium Media Pro Weekly Report"

"TMTBASE Database" is an independent, precise, and efficient professional equity investment information platform under the Titanium Media Group. Services include primary market research reports, enterprise data query services, equity crowdfunding project analysis services, and offline venture capital community services.

The report has now been fully launched on the VIP Professional version of Titanium Media.Click the link Become a professional user of Titanium Media (https://www.tmtpost.com/pro), to obtain more investment and financing information services, more primary market research report services also include:Become a professional user of Titanium Media to read all professional content without limitation.